Jazz Pharmaceuticals
JAZZ
JAZZ
405 hedge funds and large institutions have $6.55B invested in Jazz Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 161 increasing their positions, 137 reducing their positions, and 54 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
9% less capital invested
Capital invested by funds: $7.16B → $6.55B (-$612M)
19% less first-time investments, than exits
New positions opened: 44 | Existing positions closed: 54
57% less funds holding in top 10
Funds holding in top 10: 7 → 3 (-4)
Holders
405
Holding in Top 10
3
Calls
$35.5M
Puts
$30.1M
Top Buyers
| 1 | +$76.1M | |
| 2 | +$72M | |
| 3 | +$35.1M | |
| 4 |
Goldman Sachs
New York
|
+$35M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$27.8M |
Top Sellers
| 1 | -$132M | |
| 2 | -$46.3M | |
| 3 | -$24.2M | |
| 4 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$22.6M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$19.3M |